SARS-CoV-2 Neutralising Antibody Therapies: Recent Advances and Future Challenges

Investigators amalgamate contemporary understanding concerning antibodies targeting various regions, including receptor-binding domain (RBD), non-RBD, host cell targets, and cross-neutralising antibodies.